Latest autoimmune diseases Stories
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
-- Parion has a plan for the first clinical trial in patients with dry eye disease to initiate in July 2014 DURHAM, N.C., June 12, 2014 /PRNewswire/ -- Parion Sciences, Inc.
RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing
Raises Thousands to Fund Research and Support for Lupus Community NEW YORK, June 11, 2014 /PRNewswire/ -- The
Seattle Children's Research Institute and Kineta Launch the Alliance for Children's Therapeutics SEATTLE, June 11, 2014 /PRNewswire/ --
- Findings Show Positive Association Between Adherence and Anti-TNF Therapy Compared to Conventional Therapy PARIS, June 11, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced
Andrew Louis Botieri has written a new foreword to his poignant autobiographical book “A Celebration of Life: A Story of Hope, a Miracle, and the Power of Attitude”. Boston,
NEW YORK, June 10, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) launched the LRI Industry Council,
CHICAGO, June 9, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of The University of Michigan, has been selected as the second recipient of the Lupus Insight Prize.
ALBUQUERQUE, N.M., June 9, 2014 /PRNewswire/ -- Exagen Diagnostics, Inc., a leading medical diagnostic company focused in rheumatology, today announced the addition of the Avise SLE Prognostic
- A volcanic mudflow.